Vaxart Inc Stock In The News
| VXRT Stock | USD 0.76 0.08 9.52% |
The tone or emotional content of news articles related to Vaxart can affect its prices. Positive news sentiment can lead to an increase in demand for Vaxart's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Vaxart's news coverage and content from conventional and social sources shows investors' bearish mood towards Vaxart Inc. The specific impact of Vaxart news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Vaxart's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vaxart headlines in addition to utilizing other, more conventional financial analysis modules. Check out Vaxart Backtesting and Vaxart Hype Analysis.
Vaxart |
Vaxart Today Top News and Investor Outlook
Vaxart Inc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Vaxart and other traded companies coverage. We help investors stay connected with Vaxart headlines for the 23rd of April to make an informed investment decision based on correlating the impacts of news items on Vaxart Stock performance. Please note that trading solely based on the Vaxart Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.Vaxart stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Vaxart earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Vaxart that are available to investors today. That information is available publicly through Vaxart media outlets and privately through word of mouth or via Vaxart internal channels. However, regardless of the origin, that massive amount of Vaxart data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vaxart news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vaxart relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vaxart's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vaxart alpha.
Vaxart Largest EPS Surprises
Earnings surprises can significantly impact Vaxart's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-11-12 | 2020-09-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2024-03-14 | 2023-12-31 | -0.14 | -0.12 | 0.02 | 14 | ||
2023-08-03 | 2023-06-30 | -0.18 | -0.16 | 0.02 | 11 | ||
2020-05-12 | 2020-03-31 | -0.04 | -0.02 | 0.02 | 50 | ||
2022-05-09 | 2022-03-31 | -0.16 | -0.2 | -0.04 | 25 | ||
2021-05-03 | 2021-03-31 | -0.1 | -0.14 | -0.04 | 40 |
Vaxart Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Vaxart Inc Stock. Current markets are strongly bullish. About 76% of major world exchanges and indexes are currently up. See today's market update for more information.
18th of April 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at news.google.com
15th of April 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at MacroaxisInsider
11th of April 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at MacroaxisInsider
8th of April 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at MacroaxisInsider
4th of April 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at MacroaxisInsider
1st of April 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at MacroaxisInsider
27th of March 2024
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3 at finance.yahoo.com
15th of March 2024
Acquisition by Phillip Lee of 410000 shares of Vaxart at 0.78 subject to Rule 16b-3 at insidermonkey.com
29th of February 2024
Vaxart Inc Launches New Equity Plan to Attract Talent - TipRanks.com - TipRanks at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaxart in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaxart's short interest history, or implied volatility extrapolated from Vaxart options trading.
Check out Vaxart Backtesting and Vaxart Hype Analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Vaxart Stock analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Vaxart's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxart. If investors know Vaxart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxart listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 0.051 | Quarterly Revenue Growth 146.5 | Return On Assets (0.42) | Return On Equity (0.98) |
The market value of Vaxart Inc is measured differently than its book value, which is the value of Vaxart that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxart is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.